Why it matters
Sample integrity determines whether strategic conclusions are defensible in high-stakes launch decisions.
High-quality pharmaceutical evidence in GCC depends on specialist HCP recruitment quality, role validation, and auditable sample governance.
Sample integrity determines whether strategic conclusions are defensible in high-stakes launch decisions.
Programs with specialty-tier validation outperform panel-volume-only approaches in data confidence.
Lock specialty quotas early and run eligibility checks as an active fieldwork workflow, not an end-stage filter.
Verification depth
Role + license
Respondent inclusion uses role, practice, and eligibility logic before final acceptance.
Quality governance
Daily funnel
Completion, exclusion, and quota-health controls are monitored through active field windows.
Decision confidence
Audit-ready
Sample architecture remains traceable from screener design to final analytic base.